OY-3

N/A

Report date: 2023/12/21 14:10:33
NME

Base Information

Drug NameOY-3
Drug Alias NameOY3OY-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 degraders
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSchool Of Pharmacy, Fudan University
China Registration ClassN/A

Develop Information

Active CompaniesSchool Of Pharmacy, Fudan University
Inactive CompaniesN/A
Active IndicationsAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A